Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,537 | -10,116 | -7,984 | -5,873 | -2,990 |
| Depreciation Amortization | 33 | 201 | 169 | 116 | 58 |
| Accounts payable and accrued liabilities | -265 | -1,429 | -1,324 | -1,290 | -1,068 |
| Other Working Capital | -925 | -2,781 | -1,753 | -1,434 | -2,137 |
| Other Operating Activity | 366 | 1,957 | 1,856 | 1,495 | 1,177 |
| Operating Cash Flow | $-3,328 | $-12,168 | $-9,036 | $-6,986 | $-4,960 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -9 | -4 | N/A | N/A |
| Investing Cash Flow | $-14 | $-9 | $-4 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 74,002 | 3,359 | 0 | N/A | N/A |
| Financing Cash Flow | $74,002 | $3,359 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 6,227 | 15,045 | 15,045 | 15,045 | 15,045 |
| End Cash Position | 76,887 | 6,227 | 6,005 | 8,059 | 10,085 |
| Net Cash Flow | $70,660 | $-8,818 | $-9,040 | $-6,986 | $-4,960 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,328 | -12,168 | -9,036 | -6,986 | -4,960 |
| Capital Expenditure | -14 | -9 | -4 | N/A | N/A |
| Free Cash Flow | -3,342 | -12,177 | -9,040 | -6,986 | -4,960 |